P076 Safety of higher doses of melatonin in adults: A systematic review and meta-analysis
Abstract
Abstract Introduction Melatonin is commonly used for sleep and jetlag at low doses. There is less documentation on the safety of higher doses which are being increasingly used for a wide variety of conditions. This systematic review aimed to investigate the safety of higher doses of melatonin in adults. Methods We searched Medline, Scopus, Embase and PsycINFO databases from study inception until December 2019 with convenience searches until October 2020. The inclusion criteria were randomised controlled trials investigating high-dose melatonin (≥10mg) in human adults over 30 years of age. The outcomes examined were the number of adverse events (AEs), serious adverse events (SAEs) and withdrawals due to AEs. A meta-analysis was conducted on studies lasting 3 months or longer. Results 79 studies were identified with a total of 3861 participants. 29 studies (37%) made no mention of the presence or absence of AEs. Only 4 studies met the pre-specified low-risk of bias criteria for meta-analysis. In that small subset, melatonin did not cause a detectable increase in SAEs (Rate Ratio=0.88 [0.52, 1.50], p=0.64) or withdrawals due to AEs (0.93 [0.24, 3.56], p=0.92), but did appear to increase the risk of AEs such as drowsiness, headache, and dizziness (1.40, [1.15, 1.69], p<0.001). Discussion There has been limited AE reporting from high-dose melatonin studies. Based on this limited evidence, melatonin appears to have a good safety profile. Better safety reporting in future long-term…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 3,861 participants or records.
Read the paper
Related studies
- A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Evaluating the Evidence Base of Melatonin, Light Exposure, Exercise, and Complementary and Alternative Medicine for Patients with Insomnia Disorder
- Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
- Influence of evening light exposure on polysomnographically assessed night-time sleep: A systematic review with meta-analysis
- Use of melatonin in children and adolescents with idiopathic chronic insomnia: a systematic review, meta-analysis, and clinical recommendation
- Significant potential of melatonin therapy in Parkinson’s disease – a meta-analysis of randomized controlled trials
- Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.